Jin H, Wang J, Zhang G, Jiao H, Zhu J, Li Z, et al. A Chinese language multicenter retrospective examine of remoted elevated nuchal translucency related chromosome anomaly and prenatal diagnostic recommendations. Sci Rep. 2021;11:1–9.
Li X, Xuan Y, Wang J, Wang L, Papageorghiou AT, Wu Q. Crown–Rump size discordance, elevated nuchal translucency, and detection of fetal structural anomalies in twin pregnancies within the first trimester: 5 years of expertise in a Tertiary Hospital in China. J Ultrasound Med. 2022;41:971–82.
Alanen J, Leskinen M, Sairanen M, Korpimaki T, Kouru H, Gissler M, et al. Fetal nuchal translucency in extreme congenital coronary heart defects: experiences in Northern Finland. J Matern Fetal Neonatal Med. 2019;32:1454–60.
Grubman O, Hussain FN, Nelson Z, Brustman L. Maternal parvovirus B19 an infection inflicting first-trimester elevated nuchal translucency and fetal hydrops. Case Rep Obstetrics Gynecol. 2019;2019:3259760.
Baer RJ, Norton ME, Shaw GM, Flessel MC, Goldman S, Currier RJ, et al. Threat of chosen structural abnormalities in infants after elevated nuchal translucency measurement. Am J Obstet Gynecol. 2014;211:675e1–19.
Nicolaides Okay, Spencer Okay, Avgidou Okay, Faiola S, Falcon O. Multicenter examine of first‐trimester screening for trisomy 21 in 75 821 pregnancies: outcomes and estimation of the potential impression of particular person threat‐oriented two‐stage first‐trimester screening. Ultrasound Obstet Gynecol. 2005;25:221–6.
Kan AS, Lau ET, Tang W, Chan SS, Ding SC, Chan KY, et al. Entire-genome array CGH analysis for changing prenatal karyotyping in Hong Kong. PloS One. 2014;9:e87988.
Zhang Y, Lei Q, Liu J, Lin M, Luo L, Li T, et al. Selective development of mosaic cells in chromosomal evaluation of chorionic villi by standard karyotyping. Mol Cell Probes. 2020;51:101532.
Lund I, Christensen R, Petersen O, Vogel I, Vestergaard E. Chromosomal microarray in fetuses with elevated nuchal translucency. Ultrasound Obstet Gynecol. 2015;45:95–100.
Lee D, Go S, Na S, Park S, Ma J, Hwang D. Medical software of chromosomal microarray for pathogenic genomic imbalance in fetuses with elevated nuchal translucency however regular karyotype. J Genet Med. 2020;17:21–6.
Pan M, Han J, Zhen L, Yang X, Li R, Liao C, et al. Prenatal analysis of fetuses with elevated nuchal translucency utilizing an strategy primarily based on quantitative fluorescent polymerase chain response and genomic microarray. Eur J Obstet Gynecol Reprod Biol. 2016;197:164–7.
Stosic M, Levy B, Wapner R. The usage of chromosomal microarray evaluation in prenatal analysis. Obstet Gynecol Clin. 2018;45:55–68.
Egloff M, Hervé B, Quibel T, Jaillard S, Le Bouar G, Uguen Okay, et al. Diagnostic yield of chromosomal microarray evaluation in fetuses with remoted elevated nuchal translucency: a French multicenter examine. Ultrasound Obstet Gynecol. 2018;52:715–21.
Miranda J, Miño FPY, Borobio V, Badenas C, Rodriguez‐Revenga L, Pauta M, et al. Ought to cell‐free DNA testing be utilized in being pregnant with elevated fetal nuchal translucency?. Ultrasound Obstet Gynecol. 2020;55:645–51.
Maya I, Yacobson S, Kahana S, Yeshaya J, Tenne T, Agmon‐Fishman I, et al. Reduce‐off worth of nuchal translucency as indication for chromosomal microarray evaluation. Ultrasound Obstet Gynecol. 2017;50:332–5.
Zhao X-R, Gao L, Wu Y, Wang Y-L. Software of chromosomal microarray in fetuses with elevated nuchal translucency. J Matern Fetal Neonatal Med. 2020;33:1749–54.
Zhang Z, Hu T, Wang J, Li Q, Wang H, Liu S. Prenatal diagnostic worth of chromosomal microarray in fetuses with nuchal translucency larger than 2.5 mm. Biomed Res Int. 2019;2019:6504159.
Su L, Huang H, An G, Cai M, Wu X, Li Y, et al. Medical software of chromosomal microarray evaluation in fetuses with elevated nuchal translucency and regular karyotype. Mol Genet Genom Med. 2019;7:e811.
Nomenclature ISCoHC. ISCN: a global system for human cytogenomic nomenclature (2016): Karger; 2016.
Li H, Lei Y, Zhu H, Luo Y, Qian Y, Chen M, et al. The appliance of NIPT utilizing combinatorial probe-anchor synthesis to determine intercourse chromosomal aneuploidies (SCAs) in a cohort of 570 pregnancies. Mol Cytogenet. 2018;11:1–8.
Lithner CU, Kublickas M, Ek S. Being pregnant final result for fetuses with elevated nuchal translucency however regular karyotype. J Med Display. 2016;23:1–6.
Syngelaki A, Guerra L, Ceccacci I, Efeturk T, Nicolaides Okay. Affect of holoprosencephaly, exomphalos, megacystis and elevated nuchal translucency on first‐trimester screening for chromosomal abnormalities. Ultrasound Obstet Gynecol. 2017;50:45–8.
Vialard F, Gomes DM, Leroy B, Quarello E, Escalona A, Le Sciellour C, et al. Array comparative genomic hybridization in prenatal analysis: one other expertise. Fetal Diagn Ther. 2009;25:277–84.
Huang J, Poon L, Akolekar R, Choy KW, Leung TY, Nicolaides Okay. Is excessive fetal nuchal translucency related to submicroscopic chromosomal abnormalities on array CGH? Ultrasound Obstet Gynecol. 2014;43:620–4.
Grande M, Jansen F, Blumenfeld Y, Fisher A, Odibo A, Haak M, et al. Genomic microarray in fetuses with elevated nuchal translucency and regular karyotype: a scientific overview and meta‐evaluation. Ultrasound Obstet Gynecol. 2015;46:650–8.
Wentzel C, Fernström M, Öhrner Y, Annerén G, Thuresson A-C. Medical variability of the 22q11. 2 duplication syndrome. Eur J Med Genet. 2008;51:501–10.
Goldenberg P. An replace on frequent chromosome microdeletion and microduplication syndromes. Pediatr Ann. 2018;47:e198–e203.
de Ravel TJ, Ameye L, Ballon Okay, Borghgraef M, Vermeesch JR, Devriendt Okay. Early detection of chromosome 9q22. 32q31. 1 microdeletion and the nevoid basal cell carcinoma syndrome. Eur J Med Genet. 2009;52:145–7.
Leung T, Au Yeung Okay, Leung W, Leung Okay, Lo T, To W, et al. Prenatal analysis of pathogenic genomic imbalance in fetuses with elevated nuchal translucency however regular karyotyping utilizing chromosomal microarray. Hong Kong Med J. 2019;25:30–2.
Gadsbøll Okay, Petersen OB, Gatinois V, Unusual H, Jacobsson B, Wapner R, et al. Present use of noninvasive prenatal testing in Europe, Australia and the USA: a graphical presentation. Acta Obstet Gynecol Scand. 2020;99:722–30.
Ravitsky V, Roy M-C, Haidar H, Henneman L, Marshall J, Newson AJ, et al. The emergence and international unfold of noninvasive prenatal testing. Annu Rev Genom Hum Genet. 2021;22:309–38.
Tang H, Zhang Y, Ru T, Li J, Yang L, Xu Y, et al. Potential cohort examine of fetal nuchal translucency in first-trimester and being pregnant final result. Zhonghua Fu Chan Ke Za Zhi. 2020;55:94–9.
Yan H, Zhu X, Chen J, Cao Y, Kwok YKY, Chen Z, et al. Noninvasive prenatal sequencing for a number of Mendelian monogenic problems amongst fetuses with skeletal dysplasia or elevated nuchal translucency. Prenat Diagn. 2020;40:1459–65.
Xie X, Zhou H, Zhao Q, Lu Y, Meng Y. Software of expanded noninvasive prenatal check in prenatal analysis of fetuses with elevated nuchal translucency. J Matern Fetal Neonatal Med. 2021;1–6. https://doi.org/10.1080/14767058.2021.1909564.